As Table 3 and Figure 3 shows, KRAS mutation more frequently occurred in female CRC patients (p = 0.003), with mucinous (p = 0.000), perineural invasive (p = 0.046), and polypoid tumor (p = 0.004). Here, KRAS is linked to neoplasm.